Target intelligence / Profile preview

Usherin (USH2A) (USH2A)

Target
USH2A
Molecular classification
Cell adhesion molecule, Extracellular matrix protein, Transmembrane protein
01

Overview

Usherin is a large transmembrane protein encoded by the USH2A gene, primarily localized to the basement membranes of the inner ear and the connecting cilia of retinal photoreceptors (UniProt O75445). It plays a critical role in the structural integrity and functional maintenance of these sensory cells by forming a protein complex with other Usher syndrome-related proteins like ADGRV1 and whirlin (PubMed: 21665994). Mutations in USH2A are the most common cause of Usher syndrome, characterized by congenital hearing loss and progressive vision loss due to retinitis pigmentosa (NIH/GARD). Because the USH2A gene is exceptionally large, traditional gene replacement using standard AAV vectors is challenging, leading to the development of alternative strategies such as antisense oligonucleotides (ASOs) and dual-vector systems (PubMed: 31513941). Current therapeutic efforts, such as the ASO ulbevorsen (QR-421a), focus on exon skipping to restore protein function in patients with specific mutations (ProQR Therapeutics). Understanding the usherin functional complex is vital for developing precision medicines aimed at preserving sensory function in affected individuals.

Other names
Usher syndrome type-2A proteinUSH2AUsherin functional complexUsher syndrome type IIa protein
02

Mechanism of action

Antisense oligonucleotide-mediated exon skipping to restore the reading frame; Gene replacement therapy using viral vectors; CRISPR-based gene editing to correct mutations.

03

Biological functions

Sensory perception of soundVisual perceptionCell-cell adhesionMaintenance of photoreceptor cellsDevelopment of cochlear hair cells
04

Disease associations

Usher syndrome type IIaRetinitis pigmentosa 39Hearing loss
05

Safety considerations

Large gene size (21 kb) limiting AAV packagingPotential for off-target effects in gene editingRetinal inflammation following subretinal injectionEfficiency of protein restoration in mature photoreceptors
06

Interacting drugs

Ulbevorsen (QR-421a)

2 more in the full profile.

07

Biomarkers

USH2A mutation statusElectroretinogram (ERG)Optical coherence tomography (OCT)Fundus autofluorescence (FAF)

Beyond the preview

Go deeper on Usherin (USH2A) (USH2A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Usherin (USH2A) (USH2A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call